NUVL

Nuvalent, Inc.

79.23 USD
-0.02 (-0.03%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nuvalent, Inc. stock is up 18.82% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 June’s closed higher than May. In the last 8 Unusual Options Trades, there were 7 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
30 Apr 19:37 20 Sep, 2024 80.00 CALL 2000 0
30 Apr 19:38 20 Sep, 2024 85.00 CALL 80 2
30 Apr 19:39 20 Sep, 2024 85.00 CALL 83 2
03 May 16:16 21 Jun, 2024 70.00 CALL 50 1
31 May 13:50 21 Jun, 2024 60.00 PUT 250 2
06 Jun 17:58 20 Dec, 2024 95.00 CALL 83 0
07 Jun 17:44 19 Jul, 2024 80.00 CALL 50 52
20 Jun 14:45 16 Aug, 2024 85.00 CALL 316 0

About Nuvalent, Inc.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations.